HIGHLIGHTS
- who: Report and colleagues from the Department of Medicine, An-Najah National University, Nablus, PSE Department of Internal Medicine, Al-Quds have published the Article: Review began 01/26/2023 Review ended 03/06/2023 Published 03/08/2023 u00a9 Copyright, in the Journal: (JOURNAL) of March/08,/2023
- what: Our case study highlights the potential risk of piperacillin-tazobactam-induced DIHA in neonates, which can range from asymptomatic to life-threatening hemolysis, disseminated intravascular coagulopathy, and/or respiratory or renal failure.
- future: Research is needed to explore the extent of its involvement . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.